Previous studies have demonstrated that insulin resistance in PAH is not owing to an increased secretion of insulin by the pancreas, but due to the disordered lipid metabolism which may incur inflammation via oxidized LDL-mediated vascular injury (Maron et al., 2020). This evidence concerns the gene INS and Insulin resistance.